top of page
Search

Verisign: A new world staple that we want to own

  • Writer: Abacus Research
    Abacus Research
  • Aug 21, 2019
  • 1 min read

Verisign is a monopoly compounder that is just about to have pricing power, after having none for the last 8 years. Incremental operating margins are ~85%, both on volume and price growth.

The business is relatively simple and has similar characteristics to AMT, CCI in terms of certainty of growth, and almost all costs are fixed. 

We think the market is missing the longevity of price increases, the power of compounding 5% price increases, and how low the risk to FCF growth is.


Potential Upside: $285 (+37%)

Sensible Downside: $171 (-17%), based on 1% volume growth, 8% cost of capital.


 
 
 

Recent Posts

See All
RYAN / Insurance Cycle

Ryan (RYAN) is a typical hard market beneficiary, that is going through an organic growth reset. Are we there yet in terms of the reset- probably not. Timing the bottom of a cyclical market is hard. N

 
 
 
Nebius & DigitalOcean: Inference Efficiency

(NBIS, DOCN) 1. The Core AI Thesis At the core of all AI theses there are two beliefs: Demand for intelligence is ~infinite — this still seems to be true, at leas there is no data to the contrary. Com

 
 
 
SEDG, ENPH, NVTS: Plays on 800V

Everybody knows about the 800V conversion that is coming. NVDA etc have released the specs. There are many parts to that ecosystem change. Most of them are not ‘free options’ whereas SEDG and ENPH mos

 
 
 

Comments

bottom of page